Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells

Patients with severe sickle cell disease (SCD) are candidates for gene therapy using autologous hematopoietic stem cells (HSCs), but concomitant multi-organ disease may contraindicate pretransplant conditioning with full myeloablation. We tested whether nonmyeloablative conditioning, a regimen used...

Descripción completa

Detalles Bibliográficos
Autores principales: Pestina, Tamara I, Hargrove, Phillip W, Zhao, Huifen, Mead, Paul E, Smeltzer, Matthew P, Weiss, Mitchell J, Wilber, Andrew, Persons, Derek A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667717/
https://www.ncbi.nlm.nih.gov/pubmed/26665131
http://dx.doi.org/10.1038/mtm.2015.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667717/
https://www.ncbi.nlm.nih.gov/pubmed/26665131
http://dx.doi.org/10.1038/mtm.2015.45

Ejemplares similares